Best Treatment Approaches for Melena in Gastric Cancer Patients

When a patient with gastric cancer presents with hematochezia (blood in the stool) or melena (black, tarry stools), it indicates gastrointestinal bleeding, which is a serious complication requiring prompt medical intervention. The management strategy depends on the severity of the bleeding, the underlying cause, and the patient's overall clinical status.

The first step in treatment is immediate stabilization. Healthcare providers assess vital signs to determine if the patient is experiencing hypovolemic shock due to significant blood loss. Intravenous fluids and blood transfusions are administered to restore blood volume and maintain hemodynamic stability. Concurrently, laboratory tests, including complete blood counts and coagulation profiles, are conducted to evaluate the extent of anemia and clotting function.

Diagnostic evaluation is crucial to locate the source of bleeding. Upper endoscopy (gastroscopy) is typically the primary diagnostic tool, allowing direct visualization of the stomach lining to identify bleeding tumors, ulcers, or erosions. In cases where the source is unclear or the bleeding is massive, additional imaging such as CT angiography may be used to pinpoint arterial bleeding sites.

Endoscopic therapy is often the first-line treatment for active bleeding. During gastroscopy, interventions such as injection of epinephrine, thermal coagulation (using heat to seal blood vessels), placement of clips to mechanically close bleeding vessels, or application of hemostatic powders can effectively stop acute hemorrhage. These procedures are minimally invasive and can provide immediate relief.

If endoscopic methods fail to control the bleeding, interventional radiology procedures may be employed. Angiographic embolization involves threading a catheter through the arteries to the site of bleeding and injecting materials to block the affected vessel. This approach is particularly useful for patients who are not candidates for surgery or when endoscopic treatment is unsuccessful.

In severe cases where bleeding cannot be controlled by less invasive measures, surgical intervention may be necessary. Surgery aims to remove the bleeding portion of the stomach or repair damaged tissues. However, given that gastric cancer patients may have advanced disease or poor general health, surgery is considered only when other options are exhausted and the benefits outweigh the risks.

Long-term management focuses on treating the underlying gastric cancer. Depending on the stage of the disease, treatments may include chemotherapy, radiation therapy, targeted therapy, or immunotherapy. Controlling the tumor growth helps prevent recurrent bleeding. Additionally, medications such as proton pump inhibitors (PPIs) are prescribed to reduce stomach acid production, promoting healing of any ulcerated areas and reducing the risk of further bleeding.

Patients should be monitored closely for signs of recurrent bleeding, such as dizziness, weakness, or changes in stool color. Regular follow-up with an oncologist and gastroenterologist is essential to manage both the cancer and potential complications effectively. Early detection and comprehensive care significantly improve outcomes and quality of life for gastric cancer patients experiencing gastrointestinal bleeding.